Trupanion (NASDAQ:TRUP) COO John Gallagher Sells 431 Shares of Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of the business’s stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $25.08, for a total value of $10,809.48. Following the completion of the transaction, the chief operating officer directly owned 32,203 shares of the company’s stock, valued at $807,651.24. The trade was a 1.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $24.48 on Friday. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of 41.49 and a beta of 1.39. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $57.00. The firm’s 50 day simple moving average is $24.28 and its 200-day simple moving average is $26.49. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period in the previous year, the firm earned ($0.03) EPS. The business’s quarterly revenue was up 12.3% on a year-over-year basis. Analysts expect that Trupanion, Inc. will post 0.55 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on TRUP. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a report on Wednesday, July 15th. Bank of America dropped their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Cantor Fitzgerald cut their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $41.60.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Parallel Advisors LLC boosted its holdings in Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new stake in Trupanion during the 4th quarter worth approximately $64,000. Kelleher Financial Advisors acquired a new position in shares of Trupanion during the third quarter valued at approximately $74,000. Advisory Services Network LLC acquired a new position in shares of Trupanion during the third quarter valued at approximately $160,000. Finally, Fifth Third Bancorp lifted its position in shares of Trupanion by 2,911.1% in the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after acquiring an additional 7,336 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.